Mid-Morning Market Update: Markets Open Lower; Boston Scientific To Buy Out Millipede

Following the market opening Thursday, the Dow traded down 1.85 percent to 22,454.82 while the NASDAQ dipped 2.1 percent to 6,417.06. The S&P also fell, dropping 1.78 percent to 2,423.78.

Leading and Lagging Sectors

Thursday morning, the utilities shares slipped by just 1 percent. Meanwhile, top gainers in the sector included Azure Power Global Ltd (NYSE: AZRE ) up 5 percent, and Centrais Elétricas Brasileiras S.A. - Eletrobras (NYSE: EBR ) up 3 percent.

In trading on Thursday, energy shares fell 2.7 percent.

Top Headline

Boston Scientific Corporation (NYSE: BSX ) said it has exercised its option to buy the remaining shares it already does not own in privately-held Millipede, with the acquisition seen to expand the former's Structural Heart Portfolio. This deal will add to Boston Scientific's portfolio IRIS Transcatheter Annuloplasty Ring System, which is being developed for treating patients with severe mitral regurgitation, who are not able to tolerate an open-heart surgery.

Boston Scientific initially made a $90 million investment in Millipede in January, with an option to purchase the remaining shares for $325 million at closing.

Equities Trading UP

BioXcel Therapeutics, Inc. (NASDAQ: BTAI ) shares got a boost, shooting up 60 percent to $3.86 after the company's acute agitation treatment, BSCL501, received FDA Fast Track Designation.

Shares of Energous Corporation (NASDAQ: WATT ) shot up 58 percent to $7.24 after the maker of wireless charging technologies announced its first customer product approval. Energous said in a press release the U.S. Federal Communications Commission approved its Delight PSAP hearing device to be marketed and sold in the U.S.

Identiv, Inc. (NASDAQ: INVE ) shares were also up, gaining 11 percent to $3.69 after the company signed two major customers, one being a $3+ million contract.

Equities Trading DOWN

CSP Inc. (NASDAQ: CSPI ) shares dropped 14 percent to $8.78 following Q4 results. CSP posted a Q4 loss of $0.18 per share, versus a year-ago profit of $0.27 per share. Its sales declined to $19.638 million from $28.358 million.

Shares of Live Ventures Incorporated (NASDAQ: LIVE ) were down 14 percent to $7.55. Live Ventures reported FY18 earnings of $3.01 per share on sales of $199.6 million.

Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI ) was down, falling around 10 percent to $8.55. Spectrum Pharma reported submission of Biologics License Application for ROLONTIS as a treatment for chemotherapy-induced neutropenia.


In commodity news, oil traded down 1.25 percent to $45.64 while gold traded up 0.26 percent to $1,276.30.

Silver traded up 0.41 percent Thursday to $15.185, while copper fell 0.44 percent to $2.688.


European shares were lower today. The eurozone's STOXX 600 slipped 1.11 percent, the Spanish Ibex Index dipped 1.05 percent, while Italy's FTSE MIB Index declined 1.58 percent. Meanwhile the German DAX dropped 1.98 percent, and the French CAC 40 fell 0.31 percent while U.K. shares fell 1 percent.


Initial jobless claims declined 1,000 to 2016,000 in the latest week, the Labor Department reported. However, economists were expecting a 217,000 reading.

The FHFA House Price Index increased 0.3 percent in October, versus a 0.2 percent rise in September.

The Conference Board's consumer confidence index declined to 128.1 in December, versus a revised reading of 136.4 for November. However, economists projected a 133.7 reading.

The Treasury is set to auction 4-and 8-week bills at 11:30 a.m. ET.

The Treasury is set to auction 7-year notes at 1:00 p.m. ET.

Data on farm prices for November will be released at 3:00 p.m. ET.

Data on money supply for the recent week will be released at 4:30 p.m. ET.

© 2018 Benzinga does not provide investment advice. All rights reserved.

Get insight into trading platforms. Compare the best online stock brokerages.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

More Related Articles

Info icon

This data feed is not available at this time.

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.